Chilton Investment Company’s Profound Medical PROF Stock Holding History

Chilton Investment Company’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-65,000	Closed	-$378K	–	235
2025 Q1	$378K	Sell	65,000 -15,000	-19%	-$104K	0.01%	157
2024 Q4	$601K	Buy	80,000 +35,000	+78%	+$269K	0.02%	126
2024 Q3	$358K	Buy	45,000 +5,000	+13%	+$45.2K	0.01%	152
2024 Q2	$336K	Buy	40,000 +10,000	+33%	+$80.6K	0.01%	147
2024 Q1	$256K	Buy	30,000 +20,000	+200%	+$167K	0.01%	166
2023 Q4	$84.9K	Buy	+10,000	New	+$95K	﹤0.01%	170
2021 Q4	–	Sell	-10,000	Closed	-$146K	–	164
2021 Q3	$146K	Sell	10,000 -5,900	-37%	-$89.9K	﹤0.01%	157
2021 Q2	$260K	Sell	15,900 -9,100	-36%	-$169K	0.01%	132
2021 Q1	$504K	Sell	25,000 -5,000	-17%	-$120K	0.01%	117
2020 Q4	$617K	Hold	30,000	–	–	0.02%	100
2020 Q3	$529K	Hold	30,000	–	–	0.02%	106
2020 Q2	$508K	Buy	+30,000	New	+$379K	0.02%	111

Other funds holding PROF

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Chilton Investment Company's PROF Position: Q2 2025 in Review

Chilton Investment Company sold out of Profound Medical (PROF) in Q2 2025, closing a stake of 65,000 shares — an estimated $378K sold.

Chilton Investment Company first reported a position in PROF in Q2 2020 and held it in 12 quarters. The position peaked at $617K in Q4 2020. 44 funds tracked by Wall St. Rank hold PROF as of Q2 2025.

Chilton Investment Company reported no remaining Profound Medical position as of Q2 2025 after selling out during the quarter.
Chilton Investment Company sold 65,000 Profound Medical shares in Q2 2025, an estimated $378K.
Chilton Investment Company first reported a position in Profound Medical in Q2 2020 and held it in 12 quarters.
Chilton Investment Company's Profound Medical position peaked at $617K in Q4 2020.
44 funds tracked by Wall St. Rank held Profound Medical as of Q2 2025.

Based on Chilton Investment Company's 13F filing for Q2 2025, filed 14 Aug 2025.